Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Fundam Clin Pharmacol ; 23(6): 747-55, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19656206

ABSTRACT

Indomethacin (IM) is a non-steroidal anti-inflammatory drug which inhibits prostaglandin biosynthesis. It is practically insoluble in water and has the capacity to induce gastric injury. Hydroxypropyl-beta-cyclodextrin (HP-beta-CD) is an alkylated derivative of beta-CD with the capacity to form inclusion complexes with suitable molecules. IM is considered to form partial inclusion complexes with HP-beta-CD by enclosure of the p-chlorobenzoic part of the molecule in the cyclodextrin channel, reducing the adverse effects. The aim of this paper is to evaluate the gastric damage induced by the IM inclusion complex prepared by freeze-drying and spray-drying. A total of 135 Wistar rats weighing 224.4 +/- 62.5 g were put into 10 groups. They were allowed free access to water but were maintained fasted for 18 h before the first administration until the end of the experiment. IM acid-form, IM trihydrated-sodium-salt and IM-HP-beta-CD spray and freeze-dried, at normal and toxic doses, were administered through gastric cannula once/day for 3 days. Seventy-two hours after the first administration, the animals were sacrificed and the stomachs collected and prepared for morphological study by using the haematoxylin-eosin technique. Lesion indexes (rated 0/4) were developed and the type of injury was scored according to the severity of damage and the incidence of microscopic evidence of harm. Microscopic assessment demonstrated levels of injury with index one on 10-25%. The type of complexation method had different incidence but the same degree. The results show that IM inclusion complexation protects against gastric injury, reducing the incidence and the maximum degree of severity from 4 to 1, with a better performance of the spray-dried complex.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/toxicity , Gastric Mucosa/drug effects , Indomethacin/toxicity , Stomach Ulcer/pathology , beta-Cyclodextrins/chemistry , 2-Hydroxypropyl-beta-cyclodextrin , Acids , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Drug Compounding , Drug Evaluation, Preclinical , Female , Freeze Drying , Gastric Mucosa/pathology , Indomethacin/chemistry , Male , Rats , Rats, Wistar , Salts , Solubility , Stomach Ulcer/chemically induced
2.
Methods Find Exp Clin Pharmacol ; 31(2): 101-6, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19455265

ABSTRACT

The choice of appropriate animal models for the initial in vivo testing of potential anticonvulsant compounds is one of the most important steps in the successful search for new antiepileptic drugs. The purpose of this paper is to describe the most important aspects to take into account when performing the maximal electroshock seizure (MES) test in the routine laboratory screening of new antiepileptics: the conventional and threshold MES test experimental procedures, the factors affecting experimental data (laboratory conditions, administration vehicles and drug formulations, time after drug administration, and stimulus duration and site of stimulation) and the assessment of anticonvulsant activity are discussed.


Subject(s)
Anticonvulsants/pharmacology , Disease Models, Animal , Seizures/drug therapy , Animals , Anticonvulsants/administration & dosage , Drug Evaluation, Preclinical/methods , Electroshock , Humans , Mice , Pharmaceutical Vehicles/chemistry , Rats , Seizures/physiopathology , Time Factors
3.
Methods Find Exp Clin Pharmacol ; 27(8): 539-45, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16273133

ABSTRACT

The purpose of this study is to characterize the neuropharmacokinetics of lamotrigine following a single intraperitoneal dose. Adult male Wistar rats were given lamotrigine dose of 5, 10, or 20 mg/kg. Blood and brain samples were obtained at predetermined times over 120 h and analyzed by HPLC. The overall characteristics of plasma curves were determined by noncompartmental analysis with WINNONLIN. The kinetic characterization of lamotrigine distribution between plasma and brain was performed by indirect numerical deconvolution with MULTI(FILT). A linear disposition kinetics was observed within 5-20 mg/kg. The lamotrigine concentrations in brain homogenate were approx. twofold higher than in plasma. The following pharmacokinetic parameters were obtained for lamotrigine 5, 10, and 20 mg/kg, respectively: clearance of distribution from plasma to brain normalized with the volume of the brain, CL/V(h(-1)) = 4.64, 2.47, 2.40; brain-to-plasma partition coefficient, P = 0.40, 0.37, 0.34; first-order transfer rate constant from the brain to the plasma, K(h(-1)) = 11.68, 6.68, 5.96; single-pass mean transit time in the brain, MTT(h) = 0.086, 0.150, 0.168. These results indicate that lamotrigine plasma levels may be good indicators of lamotrigine levels in the brain and that higher response intensities could be expected with higher doses of lamotrigine, since efficacious concentrations are maintained for a longer period.


Subject(s)
Brain/metabolism , Triazines/administration & dosage , Triazines/pharmacokinetics , Animals , Area Under Curve , Biological Availability , Brain/drug effects , Brain/pathology , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Drug Administration Schedule , Injections, Intraperitoneal , Lamotrigine , Male , Rats , Rats, Wistar , Time Factors , Triazines/blood
4.
Fundam Clin Pharmacol ; 19(6): 669-75, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16313279

ABSTRACT

The aim of this study was to perform a pharmacokinetic/pharmacodynamic (PK/PD) modelling of lamotrigine following its acute administration to rats. Adult male Wistar rats were given 10 mg/kg of lamotrigine intraperitoneally. Plasma and brain samples were obtained at predetermined times over 120 h post-dose and analysed by liquid chromatography. The anticonvulsant profile against maximal electroshock seizure stimulation was determined over 48 h after dosing. As a linear relationship between lamotrigine plasma and brain profiles was observed, only the plasma data set was used to establish the PK/PD relationship. To fit the effect-time course of lamotrigine, the PK/PD simultaneous fitting link model was used: the pharmacokinetic parameters and dosing information were used in the one-compartment first-order model to predict concentrations, which were then used to model the pharmacodynamic data with the sigmoid Emax model, in order to estimate all the parameters simultaneously. The following parameters were obtained: Vd = 2.00 L/kg, k(abs) = 8.50 h(-1), k(el) = 0.025 h(-1), k(e0) = 3.75 h(-1), Emax = 100.0% (fixed), EC50 = 3.44 mg/L and gamma = 8.64. From these results, it can be stated that lamotrigine is extensively distributed through the body, its plasma elimination half-life is around 28 h and a lamotrigine plasma concentration of 3.44 mg/L is enough to protect 50% of the animals. When compared with humans, the plasma concentrations achieved with this dose were within the therapeutic concentration range that had been proposed for epileptic patients. With the present PK/PD modelling it was possible to fit simultaneously the time-courses of the plasma levels and the anticonvulsant effect of lamotrigine, providing information not only about the pharmacokinetics of lamotrigine in the rat but also about its anticonvulsant response over time. As this approach can be easily applied to other drugs, it becomes a useful tool for an explanatory comparison between lamotrigine and other antiepileptic drugs.


Subject(s)
Anticonvulsants/pharmacology , Anticonvulsants/pharmacokinetics , Triazines/pharmacology , Triazines/pharmacokinetics , Animals , Anticonvulsants/administration & dosage , Injections, Intraperitoneal , Lamotrigine , Male , Rats , Rats, Wistar , Triazines/administration & dosage
5.
Fundam Clin Pharmacol ; 18(1): 51-5, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14748754

ABSTRACT

As it has been previously shown that lamotrigine (LTG) accumulates in the kidney of male rats, the purpose of the present investigation was to characterize the kidney profiles of LTG and its kidney distribution pattern in male rats, in order to confirm if a preferential distribution exists and to analyse if it does or does not affect the LTG systemic pharmacokinetics. Adult male Wistar rats were intraperitoneally injected with 5, 10 and 20 mg/kg of LTG. The concentration-time profiles of LTG in plasma and whole kidney were determined over 120 h postdose. The distribution of LTG in the rat kidney was investigated in another group of rats by measuring LTG levels in the renal cortex and medulla. The LTG plasma concentration-time profiles revealed a linear relationship with dose. However, a slight increase in the LTG elimination half-life with dose was observed. In contrast, a nonlinear relationship was established between LTG kidney levels and the dose administered. Consequently, nonparallel patterns were observed between LTG plasma and kidney profiles. The LTG kidney distribution pattern revealed an accumulation of LTG in the renal cortex. The present study demonstrated that LTG distributes preferentially to the kidneys of the male rat in a dose-dependent manner and suggests that such distribution may slightly affect the systemic kinetics of the drug.


Subject(s)
Anticonvulsants/pharmacokinetics , Kidney/metabolism , Triazines/pharmacokinetics , Animals , Anticonvulsants/administration & dosage , Anticonvulsants/blood , Area Under Curve , Chromatography, High Pressure Liquid , Half-Life , Injections, Intraperitoneal , Kidney Cortex/metabolism , Kidney Medulla/metabolism , Lamotrigine , Male , Rats , Rats, Wistar , Triazines/administration & dosage , Triazines/blood
6.
Article in English | MEDLINE | ID: mdl-12076691

ABSTRACT

When the assumption of homoscedasticity is not met for analytical data, a simple and effective way to counteract the greater influence of the greater concentrations on the fitted regression line is to use weighted least squares linear regression (WLSLR). The purpose of the present paper is to stress the relevance of weighting schemes for linear regression analysis and to show how this approach can be useful in the bioanalytical field. The steps to be taken in the study of the linear calibration approach are described. The application of weighting schemes was shown by using a high-performance liquid chromatography method for the determination of lamotrigine in biological fluids as a practical example. By using the WLSLR, the accuracy of the analytical method was improved at the lower end of the calibration curve. Bioanalytical methods data analysis was improved by using the WLSLR procedure.


Subject(s)
Calibration , Regression Analysis , Chromatography, High Pressure Liquid , Lamotrigine , Sensitivity and Specificity , Triazines/analysis
7.
Fundam Clin Pharmacol ; 16(5): 331-6, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12602457

ABSTRACT

Given that administration vehicles and drug formulations can affect drug bioavailability, their influence on the pharmacokinetic profile of lamotrigine (LTG), a new-generation anti-epileptic drug, was studied in rats. Three different formulations administered intraperitoneally at a dose of 10 mg/kg were used: (1) LTG suspended in a 0.25% methylcelulose solution, (2) LTG dissolved in a 50% propylene glycol solution, and (3) LTG isethionate dissolved in distilled water. Plasma and brain homogenate levels were determined in order to evaluate vehicle-dependent drug absorption. The results demonstrated rapid absorption of LTG when it was administered as an aqueous solution, in contrast to a slower and more erratic absorption after the injection of either the lipophilic solution or the suspension. A plasma peak was achieved 15 min post-dose with the aqueous solution, with a brain peak being achieved 15 min later, while with the other formulations both plasma and brain homogenate peaks were reached 2 h after LTG administration. This study suggests that LTG isethionate dissolved in distilled water is the most suitable formulation for successful LTG pharmacokinetic studies in rats.


Subject(s)
Anticonvulsants/pharmacokinetics , Triazines/pharmacokinetics , Animals , Anticonvulsants/administration & dosage , Anticonvulsants/blood , Area Under Curve , Biological Availability , Brain/metabolism , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid , Injections, Intraperitoneal , Lamotrigine , Male , Pharmaceutical Vehicles , Rats , Rats, Wistar , Solutions , Suspensions , Triazines/administration & dosage , Triazines/blood , Water
8.
J Chromatogr B Biomed Sci Appl ; 755(1-2): 119-27, 2001 May 05.
Article in English | MEDLINE | ID: mdl-11393695

ABSTRACT

A reversed-phase high-performance liquid chromatography assay was developed and validated to determine plasma and brain lamotrigine concentrations allowing pharmacokinetic-pharmacodynamic studies of this new antiepileptic drug in patients and laboratory animals. Lamotrigine and its internal standard were extracted, under alkaline conditions, from plasma and brain homogenate, into ethyl acetate; brain proteins were previously precipitated with trichloroacetic acid. The method was linear between 0.1 and 15.0 mg/l for plasma, with a detection limit of 0.008 mg/l, and between 0.1 and 5.0 mg/l for brain homogenate, with a detection limit of 0.023 mg/l. The method proved to be simple, useful and appropriate, not only for clinical and experimental research, but also for routine monitoring of lamotrigine concentrations in patients.


Subject(s)
Anticonvulsants/analysis , Brain Chemistry , Triazines/analysis , Animals , Anticonvulsants/blood , Chromatography, High Pressure Liquid/methods , Drug Stability , Epilepsy/blood , Humans , Lamotrigine , Molecular Structure , Rats , Sensitivity and Specificity , Triazines/blood , Triazines/standards
SELECTION OF CITATIONS
SEARCH DETAIL
...